Skip to content
thestock.space

As of 6 Nov 2026, Ajooni Biotech trades at 11.8× trailing earnings, below the industry P/E of 19.5×, and the shares are 46% below their 52-week high. It earns ROCE of 7.0% and ROE of 4.4%, and sales and net profit grew 35% and 57% a year over 3 years. Debt is 0.29× equity. It is a small-cap company with a market cap of ₹51 Cr, ranked 99th of 127 Packaged Foods companies by market cap; the shares fell 41% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Mar 2025.How we calculate this

past year
Open
₹3.00
Day high
₹3.00
Day low
₹2.91
Prev. close
₹2.97
Volume
1.3 L

Health check

3 good · 3 to check
  • ReturnsBehind

    −41.2% over a year, better than 0 of 7 peers.

  • Price tagCheaper

    P/E 11.8 vs industry 19.5.

  • GrowthStrong

    Sales +34.8%, profit +56.6% a year over 3 years.

  • ProfitabilityWeak

    ROCE 7.0% vs peer median 15.3%.

  • Balance sheetSolid

    Debt 0.29× equity, interest covered 9.1×, Piotroski 6 of 9.

  • Red flags2 to check

    Return on equity is low at 4.4%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Packaged Foods

126 listed peers. Screen the industry

Small cap

₹51 Cr, #99 of 127 in its industry by size.

Defensive

Beta 0.38 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Mar 2025: sales ₹214 Cr · profit ₹4 Cr
Market cap
₹51 Cr
Small cap
P/E
11.8
Industry 19.5
Price to book
0.56
Peers 8.88
Dividend yield
0.00%
ROE
4.4%
Peers 14.8%
ROCE
7.0%
Peers 15.3%
Debt to equity
0.29
Debt ₹27 Cr
EPS (TTM)
₹0.25
Face value ₹2
OPM (TTM)
1.8%
Net margin 1.9%
Sales growth
+99.8%
Latest quarter vs a year ago
Profit growth
n/a
Year-ago quarter not reported
Price to sales
0.24
EV/EBITDA 9.8

Strengths and risks

Strengths

  • Quarterly sales up 99.8% on a year ago.
  • P/E of 11.8 against an industry P/E of 19.5.
  • Promoter stake up from 26.9% to 30.5%.

Risks to check

  • Return on equity is low at 4.4%.
  • 46% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Ajooni Biotech

Ajooni Biotech Limited provides animal nutrition and animal healthcare solutions in India. It offers compound cattle feed, cattle feed chips, came feed, cotton oil cake, mustard oil cake, and a range of feed supplements to support the nutritional requirements of livestock. Ajooni Biotech Limited was incorporated in 2010 and is based in Mohali, India.

Headquarters
Mohali
Employees
182
Sector
Consumer Defensive
ISIN
INE820Y01021
Website
ajoonibiotech.com

Price range

52 weeks

₹2.68₹5.50

Today

₹2.91₹3.00
Avg volume (3M)
3.2 L
1-year return
minus 41.2%
From 52-week high
minus 46.2%

Peers · Packaged Foods

Compare with peersScreen the whole industry
Company
NESTLEINDNestle India1,282.10plus 1.89%2,47,22960.642.76–79.9%21.0%––0.94%minus 0.5%
BRITANNIABritannia Industries4,785.00minus 3.92%1,15,25543.227.1361.2%66.7%18.4%5.7%3.0%1.89%minus 15.5%
TATACONSUMTata Consumer Products1,086.30plus 0.80%1,07,51163.34.868.3%7.6%14.0%13.9%8.6%0.92%minus 8.6%
PATANJALIPatanjali Foods411.50plus 0.19%44,77622.73.4211.2%14.8%4.2%8.7%27.0%0.98%minus 28.6%
HATSUNHatsun Agro Product1,068.10plus 0.33%23,79266.012.0720.2%19.0%10.7%11.2%29.0%1.87%plus 2.4%
MILKYMISTMilky Mist Dairy Food297.20plus 0.93%22,88091.28.88–9.7%10.1%––0.00%plus 63.7%
AWLAWL Agri Business167.00minus 0.48%21,57318.71.9815.3%11.1%2.9%8.7%21.4%0.60%minus 39.5%
AJOONIAjooni Biotech2.96minus 0.34%5111.80.567.0%4.4%1.8%34.8%56.6%0.00%minus 41.2%
Median of 7 peers–0.33%44,77660.68.8815.3%14.8%10.7%8.7%21.4%0.94%−8.6%

Quarterly results

Consolidated, ₹ crore · latest reported Mar 25
SalesSelect a row below to chart it
₹ CrMar 25
29.3
28
1.3
4.5%
1
0
0.4
1.9
19.2%
1.5

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+34.8%
Profit CAGR 3Y
+56.6%
ROE
4.4%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
74.580.1115182
–+7.6%+43.2%+59.0%
71.777.7111176
2.82.446.4
3.7%3.0%3.5%3.5%
0.30.70.92
0.50.50.30.7
10.91.12.2
−01.30.90.3
1.634.35.7
28.7%27.9%22.1%24.7%
1.12.23.44.3
–+92.2%+56.0%+28.2%
1.510.220.20–

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
17.517.534.434.4
24.125.253.656.7
5.22.21.917.8
11.92.6511.4
58.747.595.1120
8.112.713.627.6
1.82.42.76.8
15.72.118.617.4
0.80.47.51.2
32.429.852.667.3
58.747.595.1120

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−5.622.9−32−5.7
−15.87.6−17.1−15.8
21.7−3.624.815.1
0.327−24.3−6.4
−2.9−5.6−2−18
−8.417.3−34−23.8

Shareholding pattern

Source: NSE filings
30.5%
promoters
  • Promoters30.53%
  • Public69.47%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202630.53%69.47%0.00
12 Aug 202630.53%69.47%plus 3.64
30 Jun 202626.89%73.11%0.00
31 Mar 202626.89%73.11%0.00
31 Dec 202526.89%73.11%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you